These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 29692406)
1. Structural basis for the activation of acid ceramidase. Gebai A; Gorelik A; Li Z; Illes K; Nagar B Nat Commun; 2018 Apr; 9(1):1621. PubMed ID: 29692406 [TBL] [Abstract][Full Text] [Related]
2. Acid Ceramidase Deficiency in Mice Leads to Severe Ocular Pathology and Visual Impairment. Yu FPS; Sajdak BS; Sikora J; Salmon AE; Nagree MS; Gurka J; Kassem IS; Lipinski DM; Carroll J; Medin JA Am J Pathol; 2019 Feb; 189(2):320-338. PubMed ID: 30472209 [TBL] [Abstract][Full Text] [Related]
3. Acid ceramidase deficiency associated with spinal muscular atrophy with progressive myoclonic epilepsy. Gan JJ; Garcia V; Tian J; Tagliati M; Parisi JE; Chung JM; Lewis R; Baloh R; Levade T; Pierson TM Neuromuscul Disord; 2015 Dec; 25(12):959-63. PubMed ID: 26526000 [TBL] [Abstract][Full Text] [Related]
4. ASAH1 pathogenic variants associated with acid ceramidase deficiency: Farber disease and spinal muscular atrophy with progressive myoclonic epilepsy. Elsea SH; Solyom A; Martin K; Harmatz P; Mitchell J; Lampe C; Grant C; Selim L; Mungan NO; Guelbert N; Magnusson B; Sundberg E; Puri R; Kapoor S; Arslan N; DiRocco M; Zaki M; Ozen S; Mahmoud IG; Ehlert K; Hahn A; Gokcay G; Torcoletti M; Ferreira CR Hum Mutat; 2020 Sep; 41(9):1469-1487. PubMed ID: 32449975 [TBL] [Abstract][Full Text] [Related]
5. Molecular basis of acid ceramidase deficiency in a neonatal form of Farber disease: identification of the first large deletion in ASAH1 gene. Alves MQ; Le Trionnaire E; Ribeiro I; Carpentier S; Harzer K; Levade T; Ribeiro MG Mol Genet Metab; 2013 Jul; 109(3):276-81. PubMed ID: 23707712 [TBL] [Abstract][Full Text] [Related]
6. Acid Ceramidase Depletion Impairs Neuronal Survival and Induces Morphological Defects in Neurites Associated with Altered Gene Transcription and Sphingolipid Content. Kyriakou K; Lederer CW; Kleanthous M; Drousiotou A; Malekkou A Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32111095 [TBL] [Abstract][Full Text] [Related]
10. Ceramidases, roles in sphingolipid metabolism and in health and disease. Coant N; Sakamoto W; Mao C; Hannun YA Adv Biol Regul; 2017 Jan; 63():122-131. PubMed ID: 27771292 [TBL] [Abstract][Full Text] [Related]
11. Development of an acid ceramidase activity-based probe. Ouairy CM; Ferraz MJ; Boot RG; Baggelaar MP; van der Stelt M; Appelman M; van der Marel GA; Florea BI; Aerts JM; Overkleeft HS Chem Commun (Camb); 2015 Apr; 51(28):6161-3. PubMed ID: 25748248 [TBL] [Abstract][Full Text] [Related]
13. Spinal muscular atrophy and Farber disease due to ASAH1 variants: A case report. Lee BH; Mongiovi P; Levade T; Marston B; Mountain J; Ciafaloni E Am J Med Genet A; 2020 Oct; 182(10):2369-2371. PubMed ID: 32627310 [TBL] [Abstract][Full Text] [Related]
14. Spinal muscular atrophy-like phenotype in a mouse model of acid ceramidase deficiency. Nagree MS; Rybova J; Kleynerman A; Ahrenhoerster CJ; Saville JT; Xu T; Bachochin M; McKillop WM; Lawlor MW; Pshezhetsky AV; Isaeva O; Budde MD; Fuller M; Medin JA Commun Biol; 2023 May; 6(1):560. PubMed ID: 37231125 [TBL] [Abstract][Full Text] [Related]
16. Acid ceramidase and the treatment of ceramide diseases: The expanding role of enzyme replacement therapy. Schuchman EH Biochim Biophys Acta; 2016 Sep; 1862(9):1459-71. PubMed ID: 27155573 [TBL] [Abstract][Full Text] [Related]
17. Polyarticular Arthritis and Spinal Muscular Atrophy in Acid Ceramidase Deficiency. Teoh HL; Solyom A; Schuchman EH; Mowat D; Roscioli T; Farrar M; Sampaio H Pediatrics; 2016 Oct; 138(4):. PubMed ID: 27650050 [TBL] [Abstract][Full Text] [Related]
18. A case of ASAH1-related pure SMA evolving into adult-onset Farber disease. Puma A; Ezaru A; Cavalli M; Villa L; Torre F; Biancalana V; Levade T; Grecu N; Sacconi S Clin Genet; 2021 Aug; 100(2):234-235. PubMed ID: 34240417 [No Abstract] [Full Text] [Related]
19. ASAH1-related disorders: Description of 15 novel pediatric patients and expansion of the clinical phenotype. Mahmoud IG; Elmonem MA; Zaki MS; Ramadan A; Al-Menabawy NM; El-Gamal A; Mansour L; Issa MY; Abdel-Hamid MS; Abdel-Hady S; Khalifa I; Ibrahim A; Solyom A; Rolfs A; Selim L Clin Genet; 2020 Dec; 98(6):598-605. PubMed ID: 32875576 [TBL] [Abstract][Full Text] [Related]
20. Identification of a Novel Acid Sphingomyelinase Activity Associated with Recombinant Human Acid Ceramidase. He X; Schuchman EH Biomolecules; 2023 Nov; 13(11):. PubMed ID: 38002305 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]